Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
J&J Snack Foods
JJSF
$1.68B
| $13.9M | ﹤0.01% |
114,936
+114,653
| +40,513% | +$18.5M |
|
|
APLS
1527
DELISTED
Apellis Pharmaceuticals
APLS
| $13.9M | ﹤0.01% |
518,534
-20,900
| -4% | -$742K |
|
|
GMLP
1528
DELISTED
Golar LNG Partners LP
GMLP
| $13.9M | ﹤0.01% |
4,126,579
-2,850,248
| -41% | -$15.6M |
|
|
LX
1529
LexinFintech Holdings
LX
$242M
| $13.8M | ﹤0.01% |
1,558,551
-1,586
| -0.1% | -$19.6K |
|
1530
Grupo Cibest SA
CIB
$23.1B
| $13.8M | ﹤0.01% |
551,120
+255,377
| +86% | +$11.5M |
|
1531
Genesco
GCO
$406M
| $13.8M | ﹤0.01% |
1,031,068
+475,284
| +86% | +$16M |
|
|
KALV
1532
DELISTED
KalVista Pharmaceuticals
KALV
| $13.7M | ﹤0.01% |
1,790,791
+123,813
| +7% | +$1.67M |
|
1533
Prudential
PUK
$34.1B
| $13.7M | ﹤0.01% |
569,104
+404,391
| +246% | +$12.9M |
|
|
CVLY
1534
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $13.7M | ﹤0.01% |
849,263
+2,173
| +0.3% | +$44.3K |
|
1535
First Majestic Silver
AG
$9.2B
| $13.6M | ﹤0.01% |
2,200,000
+600,000
| +38% | +$5.37M |
|
1536
Teleflex
TFX
$5.91B
| $13.6M | ﹤0.01% |
46,499
-69,077
| -60% | -$24.1M |
|
1537
Pan American Silver
PAAS
$21.7B
| $13.6M | ﹤0.01% |
950,004
-2,485,372
| -72% | -$51.6M |
|
1538
NMI Holdings
NMIH
$3.37B
| $13.6M | ﹤0.01% |
1,171,828
-124,342
| -10% | -$3.29M |
|
1539
Repay Holdings
RPAY
$318M
| $13.6M | ﹤0.01% |
945,860
-164,400
| -15% | -$2.69M |
|
1540
Nucor
NUE
$62.1B
| $13.6M | ﹤0.01% |
376,521
+5,037
| +1% | +$224K |
|
1541
BioXcel Therapeutics
BTAI
$29.9M
| $13.5M | ﹤0.01% |
37,843
-19,069
| -34% | -$6.85M |
|
1542
Bridgewater Bancshares
BWB
$607M
| $13.4M | ﹤0.01% |
1,377,800
-128,171
| -9% | -$1.57M |
|
1543
Takeda Pharmaceutical
TAK
$55.9B
| $13.4M | ﹤0.01% |
883,794
+328,184
| +59% | +$5.95M |
|
1544
Builders FirstSource
BLDR
$8.03B
| $13.4M | ﹤0.01% |
1,092,944
-137,238
| -11% | -$3.1M |
|
|
AMWD
1545
DELISTED
American Woodmark
AMWD
| $13.3M | ﹤0.01% |
292,454
-19,663
| -6% | -$1.82M |
|
|
DTP
1546
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $13.3M | ﹤0.01% |
333,000
+198,000
| +147% | +$9.3M |
|
1547
Preferred Bank
PFBC
$1.27B
| $13.3M | ﹤0.01% |
392,675
+257,008
| +189% | +$13.4M |
|
1548
ManpowerGroup
MAN
$2.59B
| $13.3M | ﹤0.01% |
250,559
-249,061
| -50% | -$20.7M |
|
|
DRNA
1549
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13.3M | ﹤0.01% |
722,512
| – | – |
|
1550
Stoneridge
SRI
$196M
| $13.3M | ﹤0.01% |
791,500
+121,260
| +18% | +$3.01M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.